Delivery Order SPE2DX22D0010-SPE2D826FCC73
- Not listed
- The Defense Department's Medical Supply Chain has awarded a delivery order valued at $6,322.42 to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules, 10mg. The award, issued on December 15, 2025, with completion targeted for December 16, 2025, utilizes a firm fixed-price contract structure with no set-aside designation, indicating the award was competitively procured. The pharmaceutical product will be delivered to the vendor's location in...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 30, 2025, for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with a ceiling value of $1,055.37 and an ultimate completion date of October 1, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules 15mg with a ceiling value of $1,161.92. The contract was awarded on November 14, 2025, with an ultimate completion date of November 17, 2025, and employs firm fixed price terms with no set-aside designation. Performance will take place at the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,584.17 to AmerisourceBergen Drug Corp for Amphetamine Mix (AD) extended-release capsules, 20 mg, with a completion date of December 23, 2025. This is a firm fixed-price, non-set-aside delivery order issued to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg, with a ceiling value of $1,540.80. This competitively awarded, non-set-aside contract was executed on December 8, 2025, with an ultimate completion date of December 9, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg, with a ceiling value of $2,137.71. This competitively awarded, firm fixed-price delivery order was executed on October 23, 2025, with an ultimate completion date of October 24, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules, 25mg, with a ceiling value of $4,993.24. This is a firm fixed price delivery order awarded on November 6, 2025, with an ultimate completion date of November 7, 2025. The contract employs no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg. This competitively awarded, non-set-aside contract has a ceiling value of $2,643.72 with a firm fixed price structure and an ultimate completion date of December 22, 2025. The pharmaceutical products will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $6,125.17 on October 20, 2025, for the supply of Amphetamine Mix (AD) Extended Release Capsules, 30mg, with completion expected by October 21, 2025. This competitively awarded, firm fixed price contract was issued without a set-aside designation by the Defense Logistics Agency's Medical Supply Chain. The award represents a child contract action under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency Medical Supply Chain awarded a $2,727.34 delivery order to AmerisourceBergen Drug Corp for Amphetamine Mix (AD) Extended-Release Capsules, 20mg, with an ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The order was placed at the contractor's primary location in Conshohocken,...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FCC73Delivery Order
The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg. This firm fixed-price delivery order, valued at $3,079.41, represents a non-competitive set-aside contract and is scheduled for completion by January 2, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for controlled pharmaceutical substances reflects the company's ongoing role as a prime vendor supporting Defense Health Agency operations and other government healthcare systems through its comprehensive global pharmaceutical support vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 12/30/25 |